Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sima Lev

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Nature Communications|December 21, 2016
MicroRNA-182 targets SMAD7 to potentiate TGFβ-induced epithelial-mesenchymal transition and metastasis of cancer cellsJingyi Yu, Rong Lei, Xueqian Zhuang, et al.
Cell Death Discovery|October 25, 2024
The oncogenic axis YAP/MYC/EZH2 impairs PTEN tumor suppression activity enhancing lung tumorigenicityFederica Lo Sardo, Chiara Turco, Beatrice Messina, et al.
Cell Death & Disease|August 20, 2024
Targeting of mutant-p53 and MYC as a novel strategy to inhibit oncogenic SPAG5 activity in triple negative breast cancerValeria Canu, Sebastiano Vaccarella, Andrea Sacconi, et al.
Science Advances|October 3, 2020
Proteomic analysis of circulating extracellular vesicles identifies potential markers of breast cancer progression, recurrence, and responseYaron Vinik, Francisco Gabriel Ortega, Gordon B Mills, et al.
Theranostics|October 14, 2021
BCL-XL blockage in TNBC models confers vulnerability to inhibition of specific cell cycle regulatorsOlivier Castellanet, Fahmida Ahmad, Yaron Vinik, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 5, 2024
Programming a Ferroptosis-to-Apoptosis Transition Landscape Revealed Ferroptosis Biomarkers and Repressors for Cancer TherapyYaron Vinik, Avi Maimon, Vinay Dubey, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 29, 2022
Mouse Modeling Dissecting Macrophage-Breast Cancer Communication Uncovered Roles of PYK2 in Macrophage Recruitment and Breast TumorigenesisAnna-Katharina Müller, Ulrike A Köhler, Sébastien Trzebanski, et al.
Science Advances|September 16, 2020
Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosisNandini Verma, Yaron Vinik, Ashish Saroha, et al.
Cancer Research|October 30, 2016
Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4-NDRG1 AxisNandini Verma, Anna-Katharina Müller, Charu Kothari, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 8, 2021
Modeling Heterogeneity of Triple-Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug ResistanceFabienne Lamballe, Fahmida Ahmad, Yaron Vinik, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Nature Communications|December 21, 2016
MicroRNA-182 targets SMAD7 to potentiate TGFβ-induced epithelial-mesenchymal transition and metastasis of cancer cellsJingyi Yu, Rong Lei, Xueqian Zhuang, et al.
Cell Death Discovery|October 25, 2024
The oncogenic axis YAP/MYC/EZH2 impairs PTEN tumor suppression activity enhancing lung tumorigenicityFederica Lo Sardo, Chiara Turco, Beatrice Messina, et al.
Cell Death & Disease|August 20, 2024
Targeting of mutant-p53 and MYC as a novel strategy to inhibit oncogenic SPAG5 activity in triple negative breast cancerValeria Canu, Sebastiano Vaccarella, Andrea Sacconi, et al.
Science Advances|October 3, 2020
Proteomic analysis of circulating extracellular vesicles identifies potential markers of breast cancer progression, recurrence, and responseYaron Vinik, Francisco Gabriel Ortega, Gordon B Mills, et al.
Theranostics|October 14, 2021
BCL-XL blockage in TNBC models confers vulnerability to inhibition of specific cell cycle regulatorsOlivier Castellanet, Fahmida Ahmad, Yaron Vinik, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 5, 2024
Programming a Ferroptosis-to-Apoptosis Transition Landscape Revealed Ferroptosis Biomarkers and Repressors for Cancer TherapyYaron Vinik, Avi Maimon, Vinay Dubey, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 29, 2022
Mouse Modeling Dissecting Macrophage-Breast Cancer Communication Uncovered Roles of PYK2 in Macrophage Recruitment and Breast TumorigenesisAnna-Katharina Müller, Ulrike A Köhler, Sébastien Trzebanski, et al.
Science Advances|September 16, 2020
Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosisNandini Verma, Yaron Vinik, Ashish Saroha, et al.
Cancer Research|October 30, 2016
Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4-NDRG1 AxisNandini Verma, Anna-Katharina Müller, Charu Kothari, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 8, 2021
Modeling Heterogeneity of Triple-Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug ResistanceFabienne Lamballe, Fahmida Ahmad, Yaron Vinik, et al.
Pageof 6